ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

Study Results for Nivolumab and Pembrolizumab in Head and Neck Cancer

Everett Vokes, MD
Published Online:3:11 PM, Mon February 20, 2017

Everett Vokes, MD, John E. Ultmann professor of Medicine and Radiation Oncology, physician-in-chief, University of Chicago Medical Center, chair, Department of Medicine, University of Chicago Medicine, discusses results of studies that investigated nivolumab and pembrolizumab in head and neck cancer.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.